16 November 2022 | News
C&R Research is the only CRO that is authorized to Rave CTMS in Korea
Image credit: shutterstock
US-based Medidata, a Dassault Systèmes company, has announced that C&R Research, the largest Korean CRO, has selected Medidata's clinical operation and management solutions 'Rave CTMS (Clinical Trial Management System)' and 'Rave eTMF (electronic Trial Master File)' for their clinical trials.
This partnership will reinforce C&R Research's capability to adapt to the fast-paced clinical research environment to monitor clinical operations and comprehensively manage data.
Rave CTMS is interconnected with Rave EDC to optimize clinical operations, eliminating manual data re-entry and enabling user-centric workflows that bridge applications. Intelligent automation and workflow management will enhance efficiency and expedite a site monitoring process. All the CTMS data is integrated with eTMF, which can track the necessary information, such as milestones and tasks for each site, in one place, and data entered once and used anywhere. Using these two solutions will maximize clinical data capacity by up to 76% and reduce monitoring report time by up to 70%.
C&R Research has partnered with Medidata since 2013, and actively utilizes Rave EDC and Rave RTSM. The additional implementation of Rave CTMS and eTMF will reinforce the clinical operation system and streamline the clinical research workflow.